Naratriptan Cf

Naratriptan, the active ingredient in Naratriptan Cf, is a selective serotonin 5‑HT1B/1D receptor agonist (triptan) presented as an oral tablet for oral use. It is indicated for the acute treatment of migraine attacks in adult patients, helping to relieve headache and associated symptoms when taken at the onset of an attack.

GNH USA supplies Naratriptan Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU regulatory standards and is marketed across European Union member states.

Naratriptan is a triptan medication used to treat migraine by targeting serotonergic pathways.

- Migraine (acute): Relieves headache pain and associated symptoms when taken at the start of an attack. - Migraine with aura (acute): Provides rapid relief of aura‑related migraine episodes. - Menstrual migraine (acute): Reduces the severity of migraine attacks linked to menstrual cycles.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Drowsiness: feeling of fatigue or sleepiness. - Dry mouth: reduced salivation. - Fatigue: general lack of energy. - Paresthesia: tingling sensations in extremities.

Serious or Rare Side Effects: - Chest pain: possible cardiac discomfort. - Arrhythmia: irregular heart rhythm. - Serotonin syndrome: agitation, hyperthermia, muscle rigidity. - Severe hypertension: sudden high blood pressure. - Allergic reaction: rash, swelling, or difficulty breathing. - Ischemic events: rare stroke or myocardial infarction.

Before prescribing Naratriptan, clinicians should consider patient‑specific risk factors and monitor for adverse reactions. - Cardiovascular assessment: evaluate history of coronary artery disease, hypertension, or stroke. - Concomitant serotonergic drugs: avoid combined use with SSRIs, SNRIs, or MAO inhibitors. - Pregnancy status: discuss unknown safety profile with pregnant patients. - Lactation: weigh potential risks and benefits before use while breastfeeding. - Age considerations: use caution in elderly patients due to increased cardiovascular risk. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Naratriptan may interact with several medication classes; careful review is required.

Major Interactions (Avoid): - MAO inhibitors: risk of serotonin syndrome. - SSRIs/SNRIs: increased serotonergic activity. - Ergotamine derivatives: additive vasoconstriction. - Other triptans: cumulative triptan effect. - Certain antihypertensives: may potentiate blood pressure changes.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise naratriptan levels. - Oral contraceptives: possible reduced efficacy. - Antihistamines: may enhance drowsiness. - Alcohol: can increase dizziness. - NSAIDs: monitor for gastrointestinal irritation.